- Home
- RCON vs MIRA Comparison
RCON vs MIRA Comparison
Compare RCON & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCON | MIRA |
|---|---|---|
| Founded | 2007 | 2020 |
| Country | China | United States |
| Employees | 188 | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.0M | 33.7M |
| IPO Year | 2009 | 2023 |
Fundamental Metrics
Financial Performance| Metric | RCON | MIRA |
|---|---|---|
| Price | $1.37 | $1.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.6K | ★ 208.1K |
| Earning Date | 10-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,252,775.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.13 | $0.73 |
| 52 Week High | $7.16 | $2.45 |
Technical Indicators
Market Signals| Indicator | RCON | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 51.66 | 49.58 |
| Support Level | $1.30 | $1.44 |
| Resistance Level | $1.42 | $1.53 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 79.31 | 42.86 |
Price Performance
Historical ComparisonAbout RCON Recon Technology Ltd.
Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.